News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
277,652 Results
Type
Article (14701)
Company Profile (304)
Press Release (262643)
Multimedia
Podcasts (69)
Webinars (11)
Section
Business (79769)
Career Advice (157)
Deals (13294)
Drug Delivery (38)
Drug Development (50627)
Employer Resources (31)
FDA (5806)
Job Trends (5165)
News (144917)
Policy (10065)
Tag
Academia (921)
Accelerated approval (9)
Adcomms (14)
Allergies (70)
Alliances (21782)
ALS (99)
Alzheimer's disease (969)
Antibody-drug conjugate (ADC) (184)
Approvals (5900)
Artificial intelligence (206)
Autoimmune disease (77)
Automation (9)
Bankruptcy (105)
Best Places to Work (4564)
BIOSECURE Act (6)
Biosimilars (80)
Biotechnology (231)
Bladder cancer (88)
Brain cancer (34)
Breast cancer (279)
Cancer (2588)
Cardiovascular disease (201)
Career advice (142)
Career pathing (4)
CAR-T (179)
CDC (5)
Cell therapy (482)
Cervical cancer (11)
Clinical research (42815)
Collaboration (902)
Company closure (2)
Compensation (479)
Complete response letters (31)
COVID-19 (1086)
CRISPR (74)
C-suite (392)
Cystic fibrosis (102)
Data (3402)
Denatured (13)
Depression (69)
Diabetes (221)
Diagnostics (1350)
Digital health (9)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (142)
Drug pricing (40)
Drug shortages (3)
Duchenne muscular dystrophy (186)
Earnings (31292)
Editorial (22)
Employer branding (4)
Employer resources (29)
Events (50772)
Executive appointments (600)
FDA (7194)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (5)
Frontotemporal dementia (15)
Funding (804)
Gene editing (150)
Generative AI (15)
Gene therapy (413)
GLP-1 (466)
Government (1132)
Grass and pollen (3)
Guidances (161)
Healthcare (6606)
HIV (13)
Huntington's disease (35)
IgA nephropathy (60)
Immunology and inflammation (161)
Immuno-oncology (10)
Indications (37)
Infectious disease (1179)
Inflammatory bowel disease (145)
Inflation Reduction Act (10)
Influenza (33)
Intellectual property (137)
Interviews (18)
IPO (7327)
IRA (12)
Job creations (867)
Job search strategy (129)
Kidney cancer (9)
Labor market (19)
Layoffs (238)
Leadership (8)
Legal (1397)
Liver cancer (38)
Longevity (8)
Lung cancer (372)
Lymphoma (187)
Machine learning (19)
Management (7)
Manufacturing (290)
MASH (112)
Medical device (2646)
Medtech (2651)
Mergers & acquisitions (6488)
Metabolic disorders (612)
Multiple sclerosis (86)
NASH (13)
Neurodegenerative disease (151)
Neuropsychiatric disorders (48)
Neuroscience (1711)
NextGen: Class of 2025 (2033)
Non-profit (859)
Now hiring (28)
Obesity (272)
Opinion (117)
Ovarian cancer (114)
Pain (82)
Pancreatic cancer (119)
Parkinson's disease (186)
Partnered (11)
Patents (249)
Patient recruitment (229)
Peanut (40)
People (26311)
Pharmaceutical (47)
Pharmacy benefit managers (6)
Phase I (15132)
Phase II (19899)
Phase III (12589)
Pipeline (1891)
Policy (83)
Postmarket research (853)
Preclinical (6440)
Press Release (30)
Prostate cancer (120)
Psychedelics (47)
Radiopharmaceuticals (222)
Rare diseases (498)
Real estate (1440)
Recruiting (12)
Regulatory (9401)
Reports (19)
Research institute (956)
Resumes & cover letters (18)
Rett syndrome (15)
RNA editing (15)
RSV (16)
Schizophrenia (106)
Series A (148)
Series B (106)
Service/supplier (1)
Sickle cell disease (63)
Special edition (17)
Spinal muscular atrophy (118)
Sponsored (13)
Startups (1994)
State (1)
Stomach cancer (5)
Supply chain (29)
Tariffs (17)
The Weekly (55)
Vaccines (303)
Venture capital (46)
Weight loss (151)
Women's health (19)
Worklife (2)
Date
Last 7 days (655)
Last 30 days (1889)
Last 365 days (18191)
2025 (15716)
2024 (20551)
2023 (22419)
2022 (26827)
2021 (27809)
2020 (23366)
2019 (16227)
2018 (11741)
2017 (13747)
2016 (11841)
2015 (14350)
2014 (10400)
2013 (7493)
2012 (7552)
2011 (7620)
2010 (7438)
Location
Africa (152)
Alabama (59)
Alaska (2)
Arizona (60)
Arkansas (5)
Asia (17933)
Australia (3050)
California (6103)
Canada (1632)
China (618)
Colorado (213)
Connecticut (225)
Delaware (188)
Europe (38563)
Florida (758)
Georgia (185)
Hawaii (2)
Idaho (16)
Illinois (336)
India (26)
Indiana (141)
Iowa (8)
Japan (170)
Kansas (76)
Kentucky (7)
Louisiana (5)
Maine (11)
Maryland (664)
Massachusetts (4847)
Michigan (97)
Minnesota (221)
Mississippi (3)
Missouri (27)
Montana (14)
Nebraska (4)
Nevada (27)
New Hampshire (17)
New Jersey (1472)
New Mexico (12)
New York (1535)
North Carolina (747)
North Dakota (6)
Northern California (2903)
Ohio (157)
Oklahoma (11)
Oregon (22)
Pennsylvania (1130)
Puerto Rico (8)
Rhode Island (25)
South America (211)
South Carolina (7)
Southern California (2393)
Tennessee (33)
Texas (770)
United States (20316)
Utah (84)
Virginia (122)
Washington D.C. (36)
Washington State (507)
West Virginia (1)
Wisconsin (29)
277,652 Results for "nimbus therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nimbus Therapeutics Achieves Research Milestone in Collaboration with Lilly
February 25, 2025
·
2 min read
Press Releases
Nimbus Therapeutics Appoints Abbas Kazimi as Chief Executive Officer
March 10, 2025
·
3 min read
Press Releases
Nimbus Therapeutics Announces Initiation of First-in-Human Clinical Trial with NDI-219216, Novel WRN Inhibitor for MSI-H Tumors
April 28, 2025
·
4 min read
Press Releases
Nimbus Therapeutics Announces Clinical Progress in Oncology Therapeutic Pipeline and Provides Business Updates
January 9, 2025
·
4 min read
Business
Nimbus Therapeutics Appoints Anita Scheuber, M.D., Ph.D., as Senior Vice President, Therapeutic Area Head, Oncology
Nimbus Therapeutics today announced the appointment of Anita Scheuber, M.D., Ph.D., as Senior Vice President, Therapeutic Area Head, Oncology.
May 7, 2024
·
3 min read
Business
Nimbus Therapeutics Appoints Katharine Knobil, M.D., to Board of Directors
Nimbus Therapeutics, LLC today announced that Katharine Knobil, M.D., has been appointed to the Company’s Board of Directors.
March 12, 2024
·
3 min read
Drug Development
Nimbus Therapeutics Presents New Positive Monotherapy Phase 1/2 Clinical Data of HPK1 Inhibitor in Treatment of Advanced Solid Tumors at 2024 ASCO Annual Meeting
Nimbus Therapeutics, LLC (“Nimbus Therapeutics” or “Nimbus”) today announced the presentation of new positive data from the company’s ongoing Phase 1/2 clinical trial of NDI-101150, a novel, oral small-molecule hematopoietic progenitor kinase 1 (HPK1) inhibitor in development for the treatment of advanced solid tumors (NCT05128487).
May 23, 2024
·
4 min read
Genetown
Nimbus Therapeutics Announces Expansion of Its Immunology Drug Discovery Pipeline
Nimbus Therapeutics , LLC announced the advancement and expansion of its pipeline with the addition of discovery programs targeting innate immunity pathways.
January 5, 2024
·
3 min read
Genetown
Anagenex and Nimbus Announce a Multi-Target Collaboration to Discover Small Molecule Therapeutics for Multiple Indications
Anagenex and Nimbus Therapeutics announced they have initiated a research collaboration.
December 18, 2023
·
3 min read
Genetown
Voluntary Removal Announcement for the InfuTronix Nimbus Ambulatory Infusion Pump System
InfuTronix, LLC has announced a voluntary recall of the Nimbus Ambulatory Infusion Pump System, including Nimbus II PainPro, Nimbus II Flex, Nimbus II Plus, Nimbus II EpiD and Nimbus II EMS from the US Market due to a high number (3698) of customer complaints related to the Nimbus Infusion Pump systems dated May 2019 to August 2023.
March 20, 2024
·
6 min read
1 of 27,766
Next
